Rosnilimab

Modify Date: 2025-08-26 00:04:25

Use of Rosnilimab

Rosnilimab is a humanized IgG1-κ antibody targeting to PD-1[1][2].

Name	Rosnilimab

Description	Rosnilimab is a humanized IgG1-κ antibody targeting to PD-1[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Immunology/Inflammation >> PD-1/PD-L1
References	[1]. Pattabiraman, et al. Synthetic IL-7 and IL-7-anti-PD-1 antibody immunocytokines for cancer therapy. World Intellectual Property Organization, WO2023281484 A1 2023-01-12. [2]. Rosnilimab. IMGT/mAb-DB.

Description

Rosnilimab is a humanized IgG1-κ antibody targeting to PD-1[1][2].

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Immunology/Inflammation >> PD-1/PD-L1

References

No Any Chemical & Physical Properties